Limestone Analytics

Publication: Multiple Micronutrient Supplements Are More Cost-effective Than Iron and Folic Acid

Citation

Kashi B, Godin C, Kurzawa Z, Verney A, Busch-Hallen J, De-Regil Z. (2019). Multiple Micronutrient Supplements Are More Cost-effective than Iron and Folic Acid: Modeling Results from 3 High-Burden Asian Countries. The Journal of Nutrition, 149(7): 1222-1229. DOI: 10.1093/jn/nxz052

Date

July, 2019

Type

Peer-reviewed Journal Article

Link
Team Members
Projects

Abstract

Background
Recent evidence has encouraged low- and middle-income countries to consider transitioning from long-standing iron and folic acid supplementation (IFA) to multiple micronutrient supplementation (MMS) during pregnancy; however, global guidance is limited. To facilitate national decision-making, a cost-effectiveness model to compare supplementation approaches was developed, and applied to Pakistan, India, and Bangladesh.
Objective
We evaluated the incremental cost-effectiveness of transitioning from IFA to MMS.
Methods
The effectiveness of IFA compared with MMS during pregnancy was compared using 8 health outcomes reported in 2 meta-analyses published in 2017 (Cochrane and The Lancet). Impacts on health outcomes were aggregated using disability-adjusted life years (DALYs). Costs included the supplements and their distribution through antenatal care. The incremental cost-effective ratio (ICER) for transitioning from IFA to MMS was calculated for each country under each meta-analysis scenario, and Monte Carlo simulations were applied to generate a measure of certainty around the results.
Results
The effectiveness of transitioning from IFA to MMS under the Cochrane scenario was smaller and less certain compared with The Lancet scenario. However, even under the Cochrane scenario, MMS would avert 4,391, 5,769, and 8,578 more DALYs than IFA per 100,000 pregnancies in Pakistan, India, and Bangladesh, respectively (62.6%, 76.8%, and 82.6% certainty). The ICER of transitioning from IFA to MMS was 41.54, 31.62, and 21.26 US dollars (USD 2016) per DALY averted, respectively.
Conclusions
Despite discrepancies in the overall effect of MMS depending on the meta-analysis used, MMS is cost-effective and generates positive health outcomes for both infants and pregnant women. Whilst the effectiveness of MMS is sensitive to the prevalence of certain health outcomes under the conservative scenario (Cochrane), MMS nevertheless averts more DALYs than IFA with high certainty and should re-enter public health discussion in Pakistan, India, and Bangladesh.

News

Scenario Planning in Development Webinar

Join us this International Development Week to learn about scenario planning as a tool to navigate uncertainty in international development, and how scenario planning can be used in planning for […]

 read more
Limestone’s COVID economic modeling shows that a more-intense early-year lockdown may be better for the Canadian economy

According to Limestone’s latest modeling, a more-intense early-year lockdown may be less costly for the Canadian economy in the long run. Limestone’s STUDIO model, which provides  rapid-response policy analysis to […]

 read more

Other News

Limestone to Assist MCC in Integrating Gender & Social Inclusion into Program Development
Limestone’s Principal Economist Appointed to Royal Society of Canada COVID-19 Working Group
Limestone’s COVID-19 Service Offerings
Warmest Congratulations to the Nobel Prize Winners in Economics
Same name, same quality, now in colour!
About
Team
Friends & Advisors
Services
Key Practice Areas
News
News
Intranet
Internal Wiki
Contact
Contact Us
Get Social
Tweets

© Limestone Analytics

Sitemap